Zenas Started at Buy by Four Banks on Lead Drug Potential

Seeking Alpha15:05 ET

TEVA Applications for Prolia Biosimilar Accepted by FDA, EMA

Seeking AlphaOct 8 10:49 ET

After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study

BenzingaOct 8 09:19 ET

Biogen Announces Detailed Results From The Phase 2/3 DEVOTE Study, Highlighting The Safety And Efficacy Of A Higher Dose Nusinersen Regimen In SMA

BenzingaOct 8 07:54 ET

Morgan Stanley's List of Tax Loss Selling Stocks

Seeking AlphaOct 7 15:28 ET

Amgen Analyst Ratings

BenzingaOct 7 14:19 ET · Ratings